Differential PsaA-, PspA-, PspC-, and PdB-Specific Immune Responses in a Mouse Model of Pneumococcal Carriage
Open Access
- 1 February 2005
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 73 (2) , 1006-1013
- https://doi.org/10.1128/iai.73.2.1006-1013.2005
Abstract
Larger numbers of pneumococci were detected in the nasal tract compared to the lung, cervical lymph nodes, and spleen 1, 2, 4, 7, 14, and 21 days after nasal challenge withStreptococcus pneumoniaestrain EF3030. In this mouse model of pneumococcal carriage, peripheralS. pneumoniaepneumococcal surface adhesin A (PsaA)-specific humoral responses (immunoglobulin G2a [IgG2a] ≫ IgG1 = IgG2b > IgG3) were significantly higher than pneumococcal surface protein A (PspA)-specific, genetic toxoid derivative of pneumolysin (PdB)-specific, or pneumococcal surface protein C (PspC)-specific serum antibody levels. However, PspA-specific mucosal IgA antibody levels were significantly higher than those against PsaA, PdB, and PspC. In general, both PsaA- and PspA-specific lung-, cervical lymph node-, nasal tract-, and spleen-derived CD4+T-cell cytokine (interleukin-4, interleukin-6, granulocyte-macrophage colony-stimulating factor, gamma interferon, and tumor necrosis factor alpha) and proliferative responses were higher than those for either PspC or PdB. Taken together, these findings suggest that PsaA- and PspA-specific mucosal responses as well as systemic humoral and T helper cell cytokine responses are predominantly yet differentially induced during pneumococcal carriage.Keywords
This publication has 72 references indexed in Scilit:
- Role of Pneumococcal Surface Protein C in Nasopharyngeal Carriage and Pneumonia and Its Ability To Elicit Protection against Carriage of Streptococcus pneumoniaeInfection and Immunity, 2002
- Intranasal Vaccination with Pneumococcal Surface Protein A and Interleukin-12 Augments Antibody-Mediated Opsonization and Protective Immunity againstStreptococcus pneumoniaeInfectionInfection and Immunity, 2001
- Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistanceThe Lancet Infectious Diseases, 2001
- Modulation of Cytokines and Chemokines, Limited Pulmonary Vascular Bed Permeability, and Prevention of Septicemia and Death with Ceftriaxone and Interleukin?10 in Pneumococcal PneumoniaThe Journal of Infectious Diseases, 2000
- Selection of an Immunogenic and Protective Epitope of the PsaA Protein ofStreptococcus pneumoniaeUsing a Phage Display LibraryHybridoma, 2000
- A Pilot Study of the Predictive Value of Plasma Tumor Necrosis Factor α. and Interleukin 1β forStreptococcus pneumoniaeBacteremia in Febrile ChildrenAcademic Emergency Medicine, 1997
- Murine model of otitis media with effusion: Immunohistochemical demonstration of il‐1α antigen expressionThe Laryngoscope, 1994
- Cytokines in experimental otitis media with effusionThe Laryngoscope, 1994
- Recombinant human interleukin 6 (rhIL-6) promotes the terminal differentiation of in vivo-activated human B cells into antibody-secreting cellsCellular Immunology, 1991
- Requirement for lymphocyte-macrophage interaction in the response of mouse spleen cultures to pneumococcal polysaccharideCellular Immunology, 1971